Plunkett Research Online: Blueprint Medicines

BLUEPRINT MEDICINES (BPMC) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates BLU-285, which targets KIT .....


BLUEPRINT MEDICINES

Ticker: BPMC
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 617 374-7580
Fax:
Address: 45 Sidney Street
Cambridge, MA 02139 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Kathryn HavilandCEO/Director/President
Michael LandsittelCFO
See More
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates BLU-285, which targets KIT .....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture